Marker Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
2450 Holcombe Blvd, Suite Bcm A, Ms: Bcm251, Houston, TX
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/15/2024, 01:34 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Feb 14, 2020
SC 13G Report SC 13G Feb 14, 2019
SC 13G/A Report AMENDMENT NO. 4 TO SCHEDULE 13G Feb 4, 2019
SC 13G/A Report Feb 14, 2018
SC 13G/A Report AMENDMENT NO. 3 TO SCHEDULE 13G Jan 26, 2018
SC 13G/A Report Feb 14, 2017
SC 13G/A Report AMENDMENT NO. 2 TO SCHEDULE 13G Feb 6, 2017
SC 13G/A Report AMENDMENT NO. 2 TO SCHEDULE 13G Aug 19, 2016
SC 13G/A Report Feb 8, 2016
SC 13G/A Report AMENDMENT NO. 1 Feb 8, 2016
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Jan 29, 2016
SC 13G/A Report TAPIMMUNE INC. Jan 19, 2016
SC 13G Report SC 13G Mar 16, 2015
SC 13G Report Mar 13, 2015
SC 13G Report TAPIMMUNE INC. Jan 12, 2015
SC 13G/A Report TAPIMMUNE INC. Jan 12, 2015
SC 13G Report SCHEDULE 13G Jan 12, 2015
SC 13G Report TAPIMMUNE INC. Aug 25, 2014
SC 13G/A Report NONE Jan 22, 2014
SC 13G/A Report FORM SC 13G/A Sep 24, 2013
SC 13G Report SC 13G Sep 24, 2013
SC 13G Report NONE Apr 12, 2013
SC 13G/A Report SC 13G/A Feb 14, 2012
SC 13G Report Mar 31, 2011